Search - tctmd.com

Displaying 501 - 520 of 910

Sort: Relevancy | Date

News Daily News

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Caitlin E. Cox

December 28, 2021

News Daily News

Women Less Likely Than Men to Experience SCD During Sports

Michael O'Riordan

December 21, 2021

News Daily News

Extended DANISH Follow-up Supports ICD Benefits in Younger Nonischemic HF Patients

Todd Neale

December 14, 2021

News Features

World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard

Shelley Wood

December 13, 2021

News Daily News

Smartphone App Hears Speech Changes Indicating Fluid Buildup in HF

Caitlin E. Cox

December 10, 2021

News Daily News

Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF

L.A. McKeown

December 07, 2021

News Opinion CV Team Dispatch

December 2021 News Roundup

L.A. McKeown

December 01, 2021

Good Results but Small Numbers With JenaValve Trilogy in Severe AR

Michael O'Riordan

November 26, 2021

News Conference News PCR London Valves 2021

MitraClip Cuts HF Hospitalizations in Real-World Registry: EXPAND

Shelley Wood

November 26, 2021

News Conference News AHA 2021

Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF

Michael O'Riordan

November 19, 2021

News Conference News AHA 2021

Empagliflozin Retains Benefits in ‘True’ HFpEF Patients

Todd Neale

November 17, 2021

News Conference News

Trial of Cell Therapy for HF Misses Primary Endpoint, but Signals a Path Forward

Todd Neale

November 16, 2021

News Conference News AHA 2021

Canagliflozin Improves Quality of Life in HF Patients

Michael O'Riordan

November 16, 2021

News Conference News AHA 2021

Empagliflozin Safe in Acute HF, Improves ‘Clinical Benefit’ Over Time: EMPULSE

Shelley Wood

November 14, 2021

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Shelley Wood

November 08, 2021

News Conference News TCT 2021

GUIDE-HF Hints That Hemodynamic-Guided Management Works in HFpEF

Michael O'Riordan

November 06, 2021

Presentation TCT 2021

FUROSCIX CRLs (scPharmaceuticals)

Presenter: Daniel Bensimhon

November 06, 2021

Presentation TCT 2021

AquaPass

Presenter: Doron Aronson

November 06, 2021

Presentation TCT 2021

Treating the Lymphatic System for Acute and Chronic HF

Presenter: Marat Fudim

November 06, 2021

Presentation TCT 2021

New Approaches to Diuresis - Reprieve

Presenter: Jeffrey Testani

November 06, 2021

Advertisement

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Women Less Likely Than Men to Experience SCD During Sports

Extended DANISH Follow-up Supports ICD Benefits in Younger Nonischemic HF Patients

World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard

Smartphone App Hears Speech Changes Indicating Fluid Buildup in HF

Meta-analysis of Pivotal SGLT2 Inhibitor Trials Boosts Hopes in HFpEF

December 2021 News Roundup

Good Results but Small Numbers With JenaValve Trilogy in Severe AR

MitraClip Cuts HF Hospitalizations in Real-World Registry: EXPAND

Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF

Empagliflozin Retains Benefits in ‘True’ HFpEF Patients

Trial of Cell Therapy for HF Misses Primary Endpoint, but Signals a Path Forward

Canagliflozin Improves Quality of Life in HF Patients

Empagliflozin Safe in Acute HF, Improves ‘Clinical Benefit’ Over Time: EMPULSE

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

GUIDE-HF Hints That Hemodynamic-Guided Management Works in HFpEF

FUROSCIX CRLs (scPharmaceuticals)

AquaPass

Treating the Lymphatic System for Acute and Chronic HF

New Approaches to Diuresis - Reprieve

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content